Novasys Medical - Management

Novasys Medical, Inc. has a solid team of people dedicated to improving the quality of life for women. We have an experienced management team and an active, experienced Board of Directors.

Debra Reisenthel
President and Chief Executive Officer
Debra has more than 25 years experience in the health care industry, primarily focused on women's and children's health. She has led Novasys Medical as President and CEO since 2001, from the company’s early stages of animal studies, human clinicals and FDA clearance to the commercialization of the Renessa procedure. She has funded the company’s progress through three rounds of financing with leading medical device venture investors. Based on her fundraising success, she was asked to author a chapter entitled "The Fundraising Process: A CEO's Perspective" in Inside the Minds: Raising Capital for Health Care Companies. Prior to Novasys, Debra was Vice President and General Manager of Tyco Healthcare, Nellcor division, for more than 10 years leading the entrepreneurial perinatal business. She provided leadership and vision for the development and commercialization of the division's key product, a breakthrough technology for non-invasive oxygen monitoring of the fetus during labor and delivery. Debra commenced her career as a clinical specialist at Loyola Medical Center in Chicago. She holds a BA, an AS in Respiratory Care (CRTT, RRT), and an MBA. Debra is a leader in numerous professional organizations, including as a member of the Advisory Board to the Professional Women's Healthcare Alliance.

Charles brings extensive experience in clinical, regulatory and medical affairs with more than 14 years dedicated to medicine and the health care industry. As Chief Medical Officer, Endosurgery and Minimally Invasive Therapies at Boston Scientific, Charles led all aspects of medical and clinical affairs for the Endosurgery group, including women's health, urology, gastroenterology, pulmonology, and oncology. His team supported sales, reimbursement and regulatory strategies with well-designed clinical trials, peer-reviewed journal publications and physician support to increase the speed of new product development. As a strategic executive, Charles evaluated new technologies and companies for potential alliances, partnerships and acquisitions to expand the breadth of Boston Scientific's offerings. At Conceptus, Inc., he was Vice President, Clinical Research and Medical Affairs, responsible for large multicenter clinical trials, leading to expedited review and PMA approval by the FDA of a new female contraceptive device. Charles has conducted physician training in more than 50 countries and participated on various committees of the World Health Organization, the Population Council, the United Nations and the U.S. Agency for International Development. He is credited with numerous peer-reviewed publications focused on women's health. Charles earned his undergraduate degree from Yale University, received his M.D. degree from the College of Physicians and Surgeons of Columbia University and trained in general surgery at Columbia-Presbyterian Medical Center.

Michael Angel
Chief Financial Officer
Michael has over 30 years experience in finance, including complex debt and equity transactions and fund raising, as well as accounting, SEC reporting, operations and manufacturing, acquisitions, spin-outs, strategic planning, tax, international operations, Wall Street interface, human resources, contract negotiations and legal affairs. Michael has been the CFO of several publicly held companies, including RITA Medical Systems. RITA Medical Systems was a publicly held medical device company focused on leading edge cancer therapies and was a pioneer in the use of RF (radiofrequency) technology for medical applications. RITA’s products included devices for tumor ablation and the prevention of blood loss during liver resection surgery. As CFO, Michael had a leadership role in RITA’s acquisition by AngioDynamics, another publicly traded medical device company, in 2007. Prior to his CFO roles, he held senior financial positions with a number of technology companies, including National Semiconductor, and was the VP and Worldwide Controller of Hitachi Data Systems. Michael is a CPA and was a Senior Manager in the technology practice of PricewaterhouseCoopers. He graduated from California State University, Chico where he earned a BS degree in Business Administration, with a concentration in Accounting.

Simon Thomas
Vice President of R&D, Quality and Operations
Simon has over 22 years broad-based experience in biomedical product development and manufacturing (both single-use probes/sensors/catheters and capital equipment) with Tyco Healthcare (Nellcor), GE/Marquette (Corometrics), Novametrix Medical Systems and Physiological Instrumentation (a UK-based start-up). In addition to product development, Simon has extensive experience including clinical studies/biostatistics, regulatory strategy/submissions, intellectual property and manufacturing engineering. Prior to joining Novasys Medical in 2001, he led Nellcor's technical, clinical and regulatory functions in obtaining PMA approval of a breakthrough OB/GYN product. Simon's experience ranges from being the first R&D employee at a start-up to holding the position of Vice President of Engineering at Corometrics, leading a department of 55. Simon obtained his Bachelor of Science with Honors in Physics from Imperial College of Science and Technology in London.

Perry comes to Novasys Medical with a solid track record of more than 20 years in sales, marketing and sales management, with a strong background in urology and gynecology. For the past three years, Perry was the Vice President of Sales for Caldera Medical, a start-up company in the highly competitive female incontinence surgical market. At Caldera, Perry built an independent sales force of over 100 and led them to record growth. Previously, Perry served as Area Director for Endocare, a publicly traded manufacturer of urological devices, where he led his region to 160% annual growth and established his area as the leading territory in the company. Prior to Endocare, Perry was Director of Sales for Gyrus, a global leader in minimally invasive surgery. His region finished first in the company in 2001 with 83% revenue growth. Perry also held sales and marketing management positions with Karl Storz Endoscopy and Circon-ACMI. Perry holds a BA in Zoology and Biology with honors from the University of Tennessee.

Lauri Campbell
Vice President of Marketing and Reimbursement
Lauri joined Novasys Medical with 17 years experience in medical device marketing and sales management in both Fortune 100 and small venture-backed start-up companies. Most recently, she was an independent marketing consultant assisting small companies in launching new products in the sleep disorders, gastroenterology and cardiology markets. Prior to that, Lauri held marketing management positions at Neoforma, a publicly held Internet start-up serving the health care market. Lauri spent three years with Johnson & Johnson’s orthopaedics business unit, serving as Area Manager and Territory General Manager and successfully integrating the J&J and DePuy sales organizations in Northern California after J&J’s acquisition of DePuy. During her tenure, J&J’s market share in Northern California grew by more than 80%. Previously, Lauri held a variety of marketing and product management positions at Abbott Laboratories and Nellcor, where she led the worldwide marketing activities for an $80 million disposable and reusable sensor product line. Lauri holds a B.A. from the University of California at Los Angeles, and an MBA from the Stanford Graduate School of Business.

David Douglass (Delphi Ventures)
Douglas Kelly, MD (Alloy Ventures)
Ray Larkin, Jr., Chairman (Industry Representative)
Richard Lin ((Three Arch Partners)
Debra Reisenthel (President and CEO, Novasys Medical, Inc.)
Beckie Robertson (Versant Ventures)
Steve Sullivan, MD (Skyline Ventures)

Affinity Capital Management
GBS Venture Partners
Hercules Technology Growth Capital, Inc.
INVESCO Private Capital
JPMorgan Partners (managed by Panorama Capital)
ONSET Ventures

	Novasys Medical, Inc. has a solid team of people dedicated to improving the quality of life for women. We have an experienced management team and an active, experienced Board of Directors.
	Debra Reisenthel President and Chief Executive Officer Debra has more than 25 years experience in the health care industry, primarily focused on women's and children's health. She has led Novasys Medical as President and CEO since 2001, from the company’s early stages of animal studies, human clinicals and FDA clearance to the commercialization of the Renessa procedure. She has funded the company’s progress through three rounds of financing with leading medical device venture investors. Based on her fundraising success, she was asked to author a chapter entitled "The Fundraising Process: A CEO's Perspective" in Inside the Minds: Raising Capital for Health Care Companies. Prior to Novasys, Debra was Vice President and General Manager of Tyco Healthcare, Nellcor division, for more than 10 years leading the entrepreneurial perinatal business. She provided leadership and vision for the development and commercialization of the division's key product, a breakthrough technology for non-invasive oxygen monitoring of the fetus during labor and delivery. Debra commenced her career as a clinical specialist at Loyola Medical Center in Chicago. She holds a BA, an AS in Respiratory Care (CRTT, RRT), and an MBA. Debra is a leader in numerous professional organizations, including as a member of the Advisory Board to the Professional Women's Healthcare Alliance.
	Charles Carignan, M.D. Executive Vice President and Chief Medical Officer Charles brings extensive experience in clinical, regulatory and medical affairs with more than 14 years dedicated to medicine and the health care industry. As Chief Medical Officer, Endosurgery and Minimally Invasive Therapies at Boston Scientific, Charles led all aspects of medical and clinical affairs for the Endosurgery group, including women's health, urology, gastroenterology, pulmonology, and oncology. His team supported sales, reimbursement and regulatory strategies with well-designed clinical trials, peer-reviewed journal publications and physician support to increase the speed of new product development. As a strategic executive, Charles evaluated new technologies and companies for potential alliances, partnerships and acquisitions to expand the breadth of Boston Scientific's offerings. At Conceptus, Inc., he was Vice President, Clinical Research and Medical Affairs, responsible for large multicenter clinical trials, leading to expedited review and PMA approval by the FDA of a new female contraceptive device. Charles has conducted physician training in more than 50 countries and participated on various committees of the World Health Organization, the Population Council, the United Nations and the U.S. Agency for International Development. He is credited with numerous peer-reviewed publications focused on women's health. Charles earned his undergraduate degree from Yale University, received his M.D. degree from the College of Physicians and Surgeons of Columbia University and trained in general surgery at Columbia-Presbyterian Medical Center.
	Michael Angel Chief Financial Officer Michael has over 30 years experience in finance, including complex debt and equity transactions and fund raising, as well as accounting, SEC reporting, operations and manufacturing, acquisitions, spin-outs, strategic planning, tax, international operations, Wall Street interface, human resources, contract negotiations and legal affairs. Michael has been the CFO of several publicly held companies, including RITA Medical Systems. RITA Medical Systems was a publicly held medical device company focused on leading edge cancer therapies and was a pioneer in the use of RF (radiofrequency) technology for medical applications. RITA’s products included devices for tumor ablation and the prevention of blood loss during liver resection surgery. As CFO, Michael had a leadership role in RITA’s acquisition by AngioDynamics, another publicly traded medical device company, in 2007. Prior to his CFO roles, he held senior financial positions with a number of technology companies, including National Semiconductor, and was the VP and Worldwide Controller of Hitachi Data Systems. Michael is a CPA and was a Senior Manager in the technology practice of PricewaterhouseCoopers. He graduated from California State University, Chico where he earned a BS degree in Business Administration, with a concentration in Accounting.
	Simon Thomas Vice President of R&D, Quality and Operations Simon has over 22 years broad-based experience in biomedical product development and manufacturing (both single-use probes/sensors/catheters and capital equipment) with Tyco Healthcare (Nellcor), GE/Marquette (Corometrics), Novametrix Medical Systems and Physiological Instrumentation (a UK-based start-up). In addition to product development, Simon has extensive experience including clinical studies/biostatistics, regulatory strategy/submissions, intellectual property and manufacturing engineering. Prior to joining Novasys Medical in 2001, he led Nellcor's technical, clinical and regulatory functions in obtaining PMA approval of a breakthrough OB/GYN product. Simon's experience ranges from being the first R&D employee at a start-up to holding the position of Vice President of Engineering at Corometrics, leading a department of 55. Simon obtained his Bachelor of Science with Honors in Physics from Imperial College of Science and Technology in London.
	Perry Needham Vice President of Sales Perry comes to Novasys Medical with a solid track record of more than 20 years in sales, marketing and sales management, with a strong background in urology and gynecology. For the past three years, Perry was the Vice President of Sales for Caldera Medical, a start-up company in the highly competitive female incontinence surgical market. At Caldera, Perry built an independent sales force of over 100 and led them to record growth. Previously, Perry served as Area Director for Endocare, a publicly traded manufacturer of urological devices, where he led his region to 160% annual growth and established his area as the leading territory in the company. Prior to Endocare, Perry was Director of Sales for Gyrus, a global leader in minimally invasive surgery. His region finished first in the company in 2001 with 83% revenue growth. Perry also held sales and marketing management positions with Karl Storz Endoscopy and Circon-ACMI. Perry holds a BA in Zoology and Biology with honors from the University of Tennessee.
	Lauri Campbell Vice President of Marketing and Reimbursement Lauri joined Novasys Medical with 17 years experience in medical device marketing and sales management in both Fortune 100 and small venture-backed start-up companies. Most recently, she was an independent marketing consultant assisting small companies in launching new products in the sleep disorders, gastroenterology and cardiology markets. Prior to that, Lauri held marketing management positions at Neoforma, a publicly held Internet start-up serving the health care market. Lauri spent three years with Johnson & Johnson’s orthopaedics business unit, serving as Area Manager and Territory General Manager and successfully integrating the J&J and DePuy sales organizations in Northern California after J&J’s acquisition of DePuy. During her tenure, J&J’s market share in Northern California grew by more than 80%. Previously, Lauri held a variety of marketing and product management positions at Abbott Laboratories and Nellcor, where she led the worldwide marketing activities for an $80 million disposable and reusable sensor product line. Lauri holds a B.A. from the University of California at Los Angeles, and an MBA from the Stanford Graduate School of Business.

	David Douglass (Delphi Ventures) Douglas Kelly, MD (Alloy Ventures) Ray Larkin, Jr., Chairman (Industry Representative) Richard Lin ((Three Arch Partners) Debra Reisenthel (President and CEO, Novasys Medical, Inc.) Beckie Robertson (Versant Ventures) Steve Sullivan, MD (Skyline Ventures) Affinity Capital Management GBS Venture Partners Hercules Technology Growth Capital, Inc. INVESCO Private Capital JPMorgan Partners (managed by Panorama Capital) ONSET Ventures
	Home \| About Renessa® \| Clinical \| News \| Leadership \| Contact Us \| Legal Disclaimer Copyright © 2008 Novasys Medical, Inc. All Rights Reserved.